No recent analyst price targets found for NLTX.
Latest News for NLTX
Reviewing Intellipharmaceutics International (OTCMKTS:IPCIF) & Neoleukin Therapeutics (NASDAQ:NLTX)
Valuation and Earnings This table compares Neoleukin Therapeutics and Intellipharmaceutics International"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neoleukin Therapeutics N/A N/A -$57.56 million ($3.11) -5.68 Intellipharmaceutics International $660,000.00 0.00 -$2.89 million ($0.16) N/A Intellipharmaceutics International has…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NLTX.
U.S. House Trading
No House trades found for NLTX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.